Mary Miller - 17 Oct 2023 Form 4 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
Chief Legal Officer
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Issuer symbol
ACRV
Transactions as of
17 Oct 2023
Net transactions value
-$12,231
Form type
4
Filing time
19 Oct 2023, 19:45:41 UTC
Previous filing
28 Sep 2023
Next filing
16 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRV Common Stock Tax liability $12,231 -2,232 -5% $5.48 42,055 17 Oct 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.